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Abstract
Background: Upper gastrointestinal bleeding (UGIB) is a common cause of hospital admissions worldwide.
Aetiologies vary by sociodemographics and geography. Retrospective studies of endoscopies in much of Africa
have documented oesophageal varices as a leading cause of UGIB. Prospective studies describing outcomes and
associations with clinical factors are lacking.
Methods: We conducted a prospective cohort study at a referral hospital in Mwanza, Tanzania where
schistosomiasis is endemic. Adults admitted with haematemesis underwent laboratory workup, schistosomiasis
antigen testing and elective endoscopy, and were followed for two months for death or re-bleeding. We assessed
predictors of endoscopic findings using logistic regression models, and determined prediction rules that maximised
sensitivity and positive predictive value (PPV).
Results: Of 124 enrolled patients, 13 died within two months (10%); active schistosomiasis prevalence was 48%.
64/91(70%) patients had oesophageal varices. We found strong associations between varices and numerous
demographic or clinical findings, permitting construction of simple, high-fidelity prediction rules for oesophageal
varices applicable even in rural settings. Portal vein diameter ≥ 13 mm or water sourced from the lake yielded
sensitivity, specificity, PPV and NPV > 90% for oesophageal varices; presence of splenomegaly or water sourced from
the lake maintained sensitivity and PPV > 90%.
Conclusions: Our results guide identification of patients, via ultrasound and clinical examination, likely to have
varices for whom referral for endoscopy may be life-saving. Furthermore, they support empiric anti-schistosome
treatment for patients with UGIB in schistosome-endemic regions. These interventions have potential to reduce
UGIB-related morbidity and mortality in Africa.
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Background
Upper gastrointestinal bleeding (UGIB), defined as intra-
luminal bleeding from any location between the upper
oesophagus to the duodenum at the ligament of Treitz
[1,2], remains a common cause of hospitalisation and
death among adults worldwide [3]. In the US, UGIB is
responsible for more than 300,000 hospital admissions
annually, with a mortality rate of 7-10% [4]. At our hos-
pital in Tanzania, a diagnosis of schistosomiasis or cirrho-
sis, which was associated with UGIB in more than 2/3 of
patients, was recently documented to be the fourth lead-
ing cause of both admissions and deaths in the medicine
wards [5].
UGIB can be categorised as oesophageal variceal and
non-variceal bleeding. Underlying aetiologies of UGIB
vary markedly with geographic region and socioeco-
nomic status [6]. Determination of the aetiology of UGIB
is essential for optimising management of these critically-
ill patients. Oesophageal band ligation for patients with
bleeding oesophageal varices is the ideal treatment that
has been shown to reduce mortality [7]. In addition, if the
underlying cause of the varices can be determined and is
treatable (including infectious aetiologies such as schisto-
somiasis), pathology leading to oesophageal varices may
be diminished.
Two prior retrospective studies in Tanzania, including
one at our own hospital, have documented a startlingly
high prevalence of variceal bleeding among adults with
UGIB [8,9]. In these two studies among adults with
UGIB who underwent endoscopy, oesophageal varices
were present in 51% and 42% of patients. These rates
contrast with those from other parts of the world in
which the prevalence of variceal bleeding among those
with UGIB is < 10% [10,11]. Less common aetiologies
of UGIB in the Tanzanian studies included duodenal
ulcers (14% and 15%), gastric ulcers (11% and 5%) and
gastritis (13% and 8%). Of note, both Tanzanian studies
were retrospective reviews and therefore did not charac-
terise all patients admitted with UGIB, but only those
who were able to afford and undergo endoscopy. In
addition, these studies were limited to analysis of
data that had been recorded by clinicians in patients’
charts.
In this prospective cohort study, we sought to deter-
mine aetiologies of UGIB among adults admitted to our
hospital and demographic and clinical factors associated
with oesophageal varices that would be useful for guid-
ing the diagnosis and management of patients presenting
with UGIB to African hospitals where endoscopy is
unavailable or unaffordable. We hypothesised that the
prevalence of oesophageal varices in this region in which
schistosomiasis is hyper-endemic would be comparable to
or higher than the prevalence found in prior retrospective
studies. We further hypothesised that ongoing active
schistosomiasis would a frequent finding and would be as-
sociated with oesophageal varices.
Methods
Study setting
We aimed to enroll all adult inpatients presenting with
haematemesis to our hospital, Bugando Medical Centre
(BMC), over a period of six months. BMC is a regional
hospital that serves the Lake Zone of north-western
Tanzania (population of ~13 million) and is located in the
city of Mwanza. Schistosomiasis is highly endemic in the
region, with a documented prevalence of > 50% in many
areas [12-14]. The regional prevalence of chronic Hepatitis
B infection is ~10% [15]. All adults (≥ 14 years) who re-
ported haematemesis in the past 14 days were interviewed
for enrolment. Enrolled patients were followed for two
months after the date of admission for death or rebleed-
ing, the time period during which mortality risk is highest
[16]. Telephone contact with patients or family members
was used to determine outcomes among discharged pa-
tients. Rebleeding was defined as recurrent vomiting of
fresh blood either with shock or a decrease in haemoglo-
bin concentration of > 2 g/dL.
Data collection
Patients were interviewed and examined within 24 hours
of admission using a structured questionnaire to collect
demographic information, clinical symptoms and phys-
ical signs. Initial management of all patients with UGIB
at our hospital includes the following: evaluation of cardio-
vascular status using pulse, blood pressure, and orthostatic
changes, confirmation of adequate intravenous access,
rapid intravascular volume replacement with fluids and
red blood cells, and correction of coagulopathy with plate-
let concentrate or fresh frozen plasma. For all study
patients, ten millilitres of blood were collected for cross-
matching and to measure haemoglobin level, platelets,
mean corpuscular volume (MCV), international normal-
ised ratio (INR), partial thromboplastin time (PTT), rapid
test for HIV, hepatitis B surface antigen (HBsAg), hepatitis
C antibody (HCAb), alanine aminotransferase (ALT), as-
partate aminotransferase (AST), total and direct bilirubin,
and albumin. Decisions regarding blood transfusion were
made by the attending physicians and depended on esti-
mated blood loss, the availability of blood at the blood
bank, and the patient’s haemoglobin level.
Each patient’s urine was tested for circulating cathodic
antigen (CCA), an antigen produced by adult schisto-
some worms that is secreted into the bloodstream and ex-
creted into urine, using a point-of-care test (Rapid Medical
Diagnostics, Pretoria, South Africa). The CCA test indicates
active schistosome infection and can be positive in the
urine during infection with either species of schisto-
somes that are endemic in Tanzania (S. mansoni and
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S. haematobium), though its sensitivity is lower in S.
haematobium [17-19]. CCA point-of-care testing is used
widely and has been found to be more sensitive than the
gold standard Kato-Katz stool diagnosis of Schistosoma
mansoni, particularly for lighter infections [20]. Following
the manufacturer’s instructions, any positive line in the
“test” area was considered positive. Line intensities were
graded as “1” (test line visible but lighter than control
line), “2” (test line equal to control line), and “3” (test line
darker than control line).
Endoscopy was performed using a Pentax EPM 3500
fiberoptic endoscope (Pentax Medical, Tokyo, Japan) for
patients who were able to afford endoscopy (~100 US
dollars). Oesophageal banding was performed for pa-
tients who had bleeding varices. Injection with diluted
adrenaline was performed for bleeding peptic ulcers.
We also asked patients ten questions derived from
Oxford University’s Multidimensional Poverty Index (MPI),
which is an international measure of poverty relevant to
109 resource-poor countries [21]. The MPI is designed to
measure deprivations across the three dimensions of edu-
cation, health, and standard of living, and persons report-
ing deficiencies in at least one-third of the measures are
considered multidimensionally poor. The questionnaire is
scored from zero to six, with six indicating no poverty and
scores less than or equal to four indicating multidimen-
sional poverty (Additional file 1: Table S1).
Data analysis
Data were entered into Microsoft Excel and analysed with
Stata/IC Version 12 (College Station, Texas). Categorical
variables were summarised by frequency and percentage,
and continuous variables by median and interquartile
range (IQR). Statistical tests between categorical dependent
and independent variables were done using Chi-squared or
Fisher’s exact tests. We assessed demographic and clinical
variables for associations with oesophageal varices using
exploratory univariable logistic regression models. Age was
categorised as 14–29, 30–44, 45–59 and ≥ 60 years. Occu-
pation and water source were collapsed to binary variables
indicating fisherman and water sourced from the lake, re-
spectively. Continuous variables were assumed to have lin-
ear effects, and were checked for departures from linearity
by categorising and assessing using Wald tests. We also ex-
amined continuous variables as binary (normal/abnormal
for standard accepted medical values) to facilitate the gen-
eration of prediction rules. We created possible prediction
rules for oesophageal varices using binary variables which
reached p < 0.05 and which were immediately ascertainable
at the bedside (that is, those requiring laboratory testing
were omitted; age was also omitted since there was not a
clear linear relationship). We generated rules based on all
combinations of these binary variables, using "or" opera-
tors. Rules were categorised as clinical only or requiring
ultrasound (to measure portal vein diameter). We specified
a priori that adequate rules would have sensitivity and
positive predictive value (PPV) ≥ 90%, with highest priority
given to sensitivity. Rules with specificity and negative pre-
dictive value (NPV) ≥ 85% were preferred. For the sake of
parsimony, additional variables were only added to the pre-
diction rules if they improved test characteristics. 95%
confidence intervals (CIs) were estimated using Wilson's
formula.
Ethical issues
Ethical approval was obtained from Bugando Medical
Centre and Weill Cornell Medical College. Patients or
legal surrogates provided written informed consent for
study participation.
Results
Study population
Between 1 June and 31 December 2012, 132 adults pre-
sented to Bugando with haematemesis. Of these, four died
before they could be enrolled, two did not consent for
study participation, and two were admitted directly to the
Department of Surgery. The remaining 124/132 (94%) pa-
tients were enrolled in our study.
Demographic and medical history information of these
124 patients are presented in Table 1. Patients’ median age
was 38 (IQR 30–52) years, and the majority (60%) were
male. Many patients were peasants (36%), Fishermen (14%)
or otherwise self-employed (38%), and most had received
only primary education or less (83%). Over a third of pa-
tients (35%) met the criteria for multidimensional poverty.
Alcohol use in the past week was reported in 27 (22%). Fifty
patients (40%) had been treated with praziquantel previ-
ously, while only 47 (38%) had access to piped water.
Physical and laboratory findings
Notable physical findings at presentation included the
following: splenomegaly in 83 (67%), ascites in 47 (38%),
abnormally small liver span (< 8 cm) in 24 (19%), haemo-
dynamic instability in 26 (21%), hepatomegaly (≥ 13 cm) in
18 (15%), and new or worsening encephalopathy in four
(3%). Ultrasound examination confirmed the physical exam-
ination finding of splenomegaly in 81/83 cases (97.5%)
and the remaining two cases were borderline by ultra-
sonographic measurement.
Median admission haemoglobin level was 4.6 (3.8-6.9)
g/dL. Sixty-seven (54%) patients had mean corpuscular
volumes < 76 fl, suggesting chronic blood loss. Forty-six
(37%) patients had abnormal INRs > 1.5, and 40 (32%)
had an elevated total bilirubin level > 17 μmol/L. Trans-
aminases were elevated > 40 IU/L in 33 (27%). The urine
CCA test was positive in 59 patients (48%). Of these, it
was graded as one in 38 patients, two in 14 patients, and
three in seven patients.
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Outcomes
Thirteen of 124 enrolled patients died (10%): nine (69%)
during the first week, two (15%) during the second week
and two (15%) during the third and fourth weeks, after
they had been discharged. Sixty-two patients (50%) expe-
rienced rebleeding within two months of admission.
Of these, 53 (85%) had in-hospital rebleeding, and the
remaining nine (15%) had rebleeding that necessitated
readmission. Of note, four had severe rebleeding, all from
bleeding peptic ulcer disease, and all four underwent
surgery. The median transfused units was three (IQR
1–4 units).
Endoscopic findings
Of 124 patients enrolled in the study, 91 (73%) under-
went endoscopy and received aetiological diagnoses for
their haematemesis (Figure 1). Endoscopy was performed
at a median of two (IQR 2–5) days. Oesophageal varices
were the most common lesions found, affecting 64 (70%)
of patients who underwent endoscopy. The next most
common diagnoses were gastric and duodenal ulcers
(14 (15%) and 12 (13%), respectively).
Among the 13 deaths, seven were in the group of 33
patients who did not have endoscopy, and six were in
the 91 patients who did have endoscopy (21% versus 7%,
respectively, p = 0.02). The odds ratio for death was 3.8
(95% CI 1.2-12.4; p = 0.03) for those who did not versus
did undergo endoscopy.
Predictors of oesophageal varices
Factors significantly associated with variceal bleeding on
univariable logistic regression analysis included younger
age, living within five kilometres of the lake, working as
a fisherman, hepatitis B antigen positivity, schistosome
CCA positivity, history of praziquantel treatment, lower
blood pressure, ascites, splenomegaly, larger portal vein
diameter, lower haemoglobin level, lower mean corpuscu-
lar volume, and elevated total bilirubin (Table 2). Given
the small sample size and some strong predictors of vari-
ceal bleeding, it was not possible reliably to estimate
multivariable models. For example, the diagnosis for all
fishermen was variceal bleeding, and fitting even just
bivariable models with factors such as age and portal vein
diameter resulted in hugely inflated odds ratios.
Prediction rules for oesophageal varices
Seven variables met our criteria for inclusion in the pre-
diction rules: living within 5 km of the lake, fisherman,
water sourced from lake, history of praziquantel use, ascites,
splenomegaly and portal vein diameter ≥ 13 mm. Consider-
ing each alone, splenomegaly and portal vein diameter ≥
13 mm each met our criteria of sensitivity and PPV ≥
90% (92 [95% CI 83–97] and 94 [85–98], respectively, for
splenomegaly, and 95 [87–98] and 97 [89–99], respectively,
for portal vein diameter ≥ 13 mm; Table 3). Portal vein
diameter ≥ 13 mm offered greater specificity and NPV (93
[77–98] and 89 [73–96], respectively). Considering combi-
nations of variables, 38 met our criteria. Further restricting
to those with specificity and NPV ≥ 85%, only one clinical-
only combination remained, namely splenomegaly or water
sourced from lake, which yielded some improvement in
sensitivity and NPV over splenomegaly alone. Seven fur-
ther combinations including portal vein diameter ≥ 13 mm
remained; the rule based on portal vein diameter ≥ 13 mm
or water sourced from lake yielded optimal results (sensi-
tivity 98 [92–100], specificity 93 [77–98], PPV 97 [89–99]
and NPV 96 [81–99]).
Table 1 Demographic Characteristics of 124 Patients
Admitted to Bugando Medical Centre with Upper
Gastrointestinal Bleeding
Variable Response N = 124 %
Male sex 75 60%
Age group (years) 14-29 30 24%
30-44 52 42%
45-59 20 16%
≥ 60 22 18%
Live within 5 km of the lake Yes 80 65%
Current occupation Peasant 45 36%
Fisherman 17 14%
Other self-employed 47 38%
Civil servant 9 7%
Student 6 5%
Highest education obtained No or less than primary 26 21%
Completed primary
education
77 62%
Completed secondary
education
8 6%
Any college/university
education
13 10%
Source of water Piped 47 38%
Lake 41 33%
River 26 21%
Other (rain water,
wells, dams)
10 8%
Poverty index* ≤ 2 7 6%
2.1-4.0 36 29%
> 4.0 81 65%
Alcohol use in the past week Yes 27 22%
Aspirin or NSAID use in
the past week
Yes 2 2%
Reported history of prior
haematemesis
Yes 47 38%
Reported history of prior
praziquantel treatment
Yes 50 40%
*Poverty index > 4 indicates that a person does not have multidimensional poverty.
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Discussion
Our prospective cohort study documents the strikingly
high prevalence of variceal bleeding (70%) among 124
consecutive adult inpatients presenting with haematemesis
to a regional hospital in western Tanzania. Moreover, we
found that nearly 60% of patients presenting with haema-
temesis due to variceal bleeding and 30% presenting with
haematemesis due to other causes had evidence of active
schistosomiasis. These results are important for public
health in sub-Saharan Africa because they document high
rates of a preventable disease. Scaling up efforts to control
schistosomiasis could lead to significant reductions in mor-
bidity and mortality among the ~54 million people living
in sub-Saharan Africa who have S. mansoni infection and
are at risk for periportal fibrosis, oesophageal varices, and
death [22].
To our knowledge, this is the first prospective study to
determine endoscopic diagnoses, presenting features, and
outcomes among adults with UGIB in East Africa. Two
recent retrospective studies done in Tanzania have docu-
mented comparably high rates of oesophageal varices
among patients with UGIB (41%-52%) [8,9]. Our study,
conducted in a region in which the prevalence of schisto-
somiasis is one of the highest in the world, additionally de-
scribes numerous factors that were highly associated with
oesophageal varices in patients presenting with haematem-
esis. Associated characteristics included demographics,
clinical findings at the time of admission, and documented
active infections (hepatitis B and schistosomiasis). Taken
together, these data suggest that patients who live near the
lakeside and/or fished and present with signs of portal
hypertension and liver dysfunction are highly likely to have
variceal bleeding.
Identification and appropriate management of patients
who have oesophageal varices is urgent because each epi-
sode of variceal haemorrhage carries 18-30% risk of death
within six weeks with increasing mortality in the ensuing
months and years [23-25]. These mortality estimates are
from wealthier settings in which cirrhosis, which is associ-
ated with higher mortality, is more common but additional
management options such as sclerotherapy and portosyste-
mic shunting are available. We believe that mortality in
resource-limited settings, particularly when patients often
present with more advanced disease or live remotely from
advanced medical care, may be higher. Moreover, endos-
copy is a scarce resource in Tanzania, and when combined
with transportation expenses, it easily costs over a month’s
wages for an average rural patient. Therefore, identifica-
tion of patients most likely to benefit from endoscopy
(e.g., those with oesophageal varices that can be banded
or sclerosed) is additionally important from a healthcare
cost and resource utilisation perspective.
We determined clinical prediction rules with high sen-
sitivity, specificity, PPV, and NPV that can be used in
Figure 1 Endoscopically- and/or medically-confirmed aetiologies of upper gastrointestinal bleeding among 91 patients admitted to
Bugando Medical Centre.
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Table 2 Demographic and Clinical Predictors of Oesophageal Varices among 91 Patients with Endoscopic Diagnoses
Demographic or
clinical parameter
Patients without varices (N = 27)
median (IQR) or number (%)
Patients with varices (N = 64)
median (IQR) or number (%)
Univariable odds
ratio [95% CI]*
P-value*
Sex 0.88
Female 11 (41%) 25 (39%) 1 [reference]
Male 16 (59%) 39 (61%) 1.07 [0.43-2.68]
Age, years 0.002
15-29 6 (22%) 11 (17%) 1 [reference]
30-44 6 (22%) 35 (55%) 3.18 [0.85-11.9]
45-59 3 (11%) 12 (19%) 2.18 [0.44-10.9]
≥ 60 12 (44%) 6 (9%) 0.27 [0.07-1.10]
Live within 5 km of the lake < 0.001
No 19 (70%) 11 (17%) 1 [reference]
Yes 8 (30%) 53 (83%) 11.4 [4.00-32.7]
Working as a fisherman 0.002***
No 27 (100%) 48 (75%) ***
Yes 0 16 (25%)
Highest education obtained 0.10
No or less than primary 8 (30%) 11 (17%) 1 [reference]
Completed primary 12 (44%) 45 (70%) 2.73 [0.90-8.29]
Completed secondary 1 (4%) 3 (5%) 2.18 [0.19-25.0]
Any college/university 6 (22%) 5 (8%) 0.61 [0.14-2.71]
Source of water < 0.001***
Piped/river/other 27 (100%) 31 (48%) ***
Lake 0 33 (52%)
Poverty index** 0.61
≤ 4 7 (26%) 20 (31%) 1 [reference]
> 4 20 (74%) 44 (69%) 0.77 [0.28-2.11]
Alcohol use in the past week 0.19
No 19 (70%) 53 (83%) 1 [reference]
Yes 8 (30%) 11 (17%) 0.49 [0.17-1.41]
Aspirin/NSAID use in the past week 0.54
No 26 (96%) 62 (98%) 1 [reference]
Yes 1 (4%) 1 (2%) 0.41 [0.02-6.85]
Prior medical history
Reported history of prior haematemesis 0.06
No 21 (78%) 36 (56%) 1 [reference]
Yes 6 (22%) 28 (44%) 2.72 [0.97-7.65]
Reported history of prior praziquantel use 0.008
No 22 (81%) 32 (50%) 1 [reference]
Yes 5 (19%) 32 (50%) 4.40 [1.48-13.1]
Clinical examination
Mean arterial blood pressure (mmHg) 83 (70–87) 70 (63–82) 0.67 [0.49-0.93]+ 0.02
Heart rate (beats per minute) 98 (88–110) 105 (86–111) 1.00 [0.98-1.03] 0.78
Ascites 0.002
No 24 (89%) 32 (50%) 1 [reference]
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smaller hospitals where ultrasounds but not endoscopy are
available, and in even smaller clinics using history and
physical examination alone. When ultrasound is available,
the single finding of portal vein diameter ≥ 13 mm has
over 90% sensitivity, specificity and PPV for oesophageal
varices. When ultrasound is not available, the presence of
splenomegaly alone maintains a sensitivity and PPV > 90%,
allowing focused use of the scarce resource of endoscopy
for patients in whom intervention is possible. These clin-
ical rules therefore represent a powerful tool that can be
used to suggest which patients with haematemesis are
highly likely to have oesophageal varices. These patients
Table 2 Demographic and Clinical Predictors of Oesophageal Varices among 91 Patients with Endoscopic Diagnoses
(Continued)
Yes 3 (11%) 32 (50%) 8.00 [2.18-29.2]
Hepatomegaly 0.98
No 24 (89%) 57 (89%) 1 [reference]
Yes 3 (11%) 7 (11%) 0.92 [0.23-4.12]
Splenomegaly < 0.001
No 23 (85%) 5 (8%) 1 [reference]
Yes 4 (15%) 59 (92%) 67.9 [16.7-275]
Encephalopathy 0.54
No 26 (96%) 63 (98%) 1 [reference]
Yes 1 (4%) 1 (2%) 0.41 [0.02-6.85]
Investigations
Hepatitis B surface Ag 0.03
Negative 25 (93%) 45 (70%) 1 [reference]
Positive 2 (7%) 19 (30%) 5.27 [1.14 – 24.5]
Anti-Hepatitis C Ab 0.54
Negative 26 (96%) 63 (98%) 1 [reference]
Positive 1 (4%) 1 (2%) 0.41 [0.02-6.85]
HIV 0.63
Negative 26 (96%) 60 (94%) 1 [reference]
Positive 1 (4%) 4 (6%) 1.73 [0.18 – 16.3]
Schistosoma CCA 0.01
Negative 19 (70%) 26 (41%) 1 [reference]
Positive 8 (30%) 38 (59%) 3.47 [1.32-9.11]
Portal vein, mm < 0.001
< 13 25 (93%) 3 (5%) 1 [reference]
≥ 13 2 (7%) 61 (95%) 254 [40.0-1614]
Haemoglobin (g/dL) 6.0 (4.0-9.9) 4.2 (3.6-5.6) 0.76 [0.64-0.91] 0.002
MCV (fl) 82 (71–89) 74 (67–80) 0.59 [0.37-0.92]+ 0.02
Platelets (109/L) 150 (103–215) 103 (55–143) 0.70 [0.45-1.11]++ 0.13
PTT (seconds) 28 (26–32) 30 (27–35) 1.69 [0.75-3.79]+ 0.20
INR (ratio) 1.2 (1.0-1.4) 1.4 (1.1-1.7) 1.37 [0.51-3.63] 0.53
Total bilirubin (μmol/L) 8.8 (5.2-12.7) 13.2 (7.7-21.7) 1.07 [1.01-1.16] 0.04
Albumin (g/L) 35 (30–44) 32 (28–39) 0.74 [0.44-1.24]+ 0.25
AST (U/L) 22 (19–29) 28 (19–49) 1.23 [0.96-1.57]+ 0.10
ALT (U/L) 17 (14–27) 23 (15–47) 1.20 [0.97-1.49] 0.09
*Results from logistic regression models (Wald p-values).
**Poverty index > 4 indicates that a person does not have multidimensional poverty.
***Unable to calculate odds ratio due to a zero; p-value from Fisher's exact test.
+Per 10 units higher.
++Per 100 units higher.
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should be referred for urgent endoscopy and counselled
that endoscopy may be life-saving.
Our data demonstrates active schistosome infection in
nearly half of adults presenting with haematemesis. Simi-
lar rates of schistosomiasis in community-based studies of
adults in this region have also been documented [12-14].
These results contrast with the common teaching in sub-
Saharan Africa that schistosomiasis is predominantly an
infection of children and that adults presenting with UGIB
due to schistosomiasis have past but not present infection.
The prevalence of schistosomiasis in endemic regions
peaks between age ten and 20, and adults can develop par-
tial immunity but many still remain infected [26,27]. For
this reason, we advocate universal testing and treatment
for schistosomiasis and/or empiric anti-schistosome treat-
ment as an integral component of managing patients who
present with UGIB in schistosome-endemic settings, par-
ticularly given the evidence that schistosomal liver path-
ology will continue to worsen in the setting of ongoing
schistosome infection but may regress following anti-
schistosome treatment [28,29].
In addition, our findings suggest that current schisto-
somiasis control efforts in Tanzania and many other coun-
tries in sub-Saharan Africa are inadequate. Many nations
with limited healthcare funds focus schistosomiasis treat-
ment efforts on schoolchildren despite the World Health
Organization’s recommendations that both children and
adults living in highly-endemic areas should be treated an-
nually for schistosomiasis [30]. The average lifespan of the
S. mansoni worm is 3–5 years, while the time from infec-
tion to development of liver fibrosis typically takes 5–15
years [26]. Therefore, the finding of active schistosomiasis
in these adults presenting with end-stage liver fibrosis sug-
gests that they have been subject to ongoing exposure and
re-infection for many years. In the absence of the ability to
eliminate schistosomiasis altogether through behavioural
change, clean water provision, and improved sanitation,
the next-best remedy is to decrease worm burden and
morbidity through routine treatment for both children
and adults.
Our study has several limitations. First, we were not able
to perform liver biopsies in this resource-limited setting in
order to corroborate our diagnoses histopathologically.
The ability to do so would have been most useful to deter-
mine the predominant disease in the 11 patients who had
both active schistosome infection and Hepatitis B antigen
positivity. Second, we limited our study population to pa-
tients with haematemesis in the past 14 days in order to
ensure that only patients with true upper gastrointestinal
bleeding were enrolled. It is possible that this led to the
exclusion of patients with less acute or lower-volume
upper gastrointestinal bleeding.
Conclusions
In conclusion, our prospective data reveals extremely
high rates of oesophageal varices and active schistosom-
iasis among adults presenting with haematemesis to a
referral hospital in a region in which both schistosomia-
sis and hepatitis B are endemic. Oesophageal varices were
strongly associated with specific ultrasonographic and
physical examination findings that can be assessed even in
the most rural hospitals. Our data provides guidance for
Table 3 Possible Prediction Rules for Oesophageal Varices
Rule Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
Single clinical condition:
Splenomegaly 92 (83–97) 85 (68–94) 94 (85–98) 82 (64–92)
Live within 5 km of the lake 83 (72–90) 70 (52–84) 87 (76–93) 63 (46–78)
Water sourced from lake 52 (40–63) 100 (88–100) 100 (90–100) 47 (34–59)
Ascites 50 (38–62) 89 (72–96) 91 (78–97) 43 (31–56)
History of praziquantel 50 (38–62) 81 (63–92) 86 (72–94) 41 (29–54)
Fisherman 25 (16–37) 100 (88–100) 100 (81–100) 36 (26–47)
Ultrasound single condition:
Portal vein diameter ≥ 13 mm 95 (87–98) 93 (77–98) 97 (89–99) 89 (73–96)
Combinations of clinical conditions:
Splenomegaly or water sourced from lake 94 (85–98) 85 (68–94) 94 (85–98) 85 (68–94)
Combinations of clinical and ultrasound conditions:
Portal vein diameter ≥ 13 mm or water sourced from lake 98 (92–100) 93 (77–98) 97 (89–99) 96 (81–99)
Portal vein diameter ≥ 13 mm or water sourced from lake or ascites 98 (92–100) 89 (72–96) 95 (87–98) 96 (80–99)
Portal vein diameter ≥ 13 mm or fisherman 95 (87–98) 93 (77–98) 97 (89–99) 89 (73–96)
Portal vein diameter ≥ 13 mm or ascites 95 (87–98) 89 (72–96) 95 (87–98) 89 (72–96)
This table shows single-condition rules and rules which met our primary criteria of sensitivity and PPV ≥ 90%, and additionally had specificity and NPV ≥ 85%.
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identification of patients likely to have varices for whom
referral for endoscopy may be life-saving, and it also sup-
ports empiric praziquantel treatment for patients in low-
resource, schistosome-endemic regions who present with
UGIB. Both of these simple interventions have the poten-
tial to reduce morbidity and mortality associated with
UGIB in sub-Saharan Africa.
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